|
KMID : 0363320230440030506
|
|
Journal of Korean Oriental Internal Medicine
2023 Volume.44 No. 3 p.506 ~ p.522
|
|
|
Analysis of Herbal Medicine in the Clinical Guidelines of Korea and China for COVID-19
|
|
Yang Seung-Bo
Jeong A-Ram
|
|
|
Abstract
|
|
|
|
COVID-19 is an acute infectious disease caused by SARS-CoV-2 that has infected more than 700 million people around the world and left many deaths. In Korea and China, Korean medicine and Traditional Chinese Medicine were used to treat COVID-19, and the key element between them was herbal medicine. Clinical guidelines for herbal medicine have been published in Korea and China. In this review, the Korean and Chinese guidelines were compared and analyzed. This review was based on the latest revised clinical guidelines. The Korean guidelines covered all three guidelines published by The Association of Korean Medicine and The KM Professor Council of Internal Medicine of the Respiratory System. The Chinese guideline was published by the China National Health Commission. Based on research trends, a comprehensive comparison was made of the suggested prescriptions for each severity of COVID-19. It is expected that this review will be used as a reference for the treatment of COVID-19 or new infectious diseases in the future.
|
|
|
KEYWORD
|
|
|
COVID-19, clinical guideline, herbal medicine, Korean medicine, traditional Chinese medicine
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|